Key result
Uremia was associated with reduced postheparin lipolytic activity in all 10 patients, but serum triglycerides were elevated in only six, suggesting other factors drive hyperlipemia.
Observational (n=10)
Reduced postheparin lipolytic activity in uremia may be partly due to a circulating inhibitor, but other factors are likely more important for developing hypertriglyceridemia.
Answers are grounded in this paper and cite their sources.
Reduced postheparin lipolytic activity in uremia does not invariably raise triglycerides; leaves open other drivers and requires prospective confirmation.
The pathogenesis of hypertriglyceridemia associated with renal failure was studied in 10 non-nephrotic uremic patients undergoing twice-weekly hemodialysis. Fasting plasma triglyceride levels, lipoprotein electrophoretic patterns, and postheparin lipolytic activity (PHLA), using both Ediol and rat chylomicrons as substrate, were determined in each patient. Although PHLA activity was reduced in all patients, serum triglyceride levels were elevated to over 190 mg/100 ml in only six. Plasma from the 10 uremic patients usually inhibited PHLA from normal subjects, but often the degree of inhibition was small and did not correlate with the degree of impairment of PHLA. These results suggest that reduced PHLA may be related in part to a circulating plasma inhibitor, but that factors other than plasma clearance of triglyceride are more important in the development of the hyperlipemia seen in chronic uremia.
No takes yet. Share an insight, caveat, or question.
Boyer et al. (1970) conducted an observational in Uremia with hypertriglyceridemia (n=10). Uremia vs. Normal subjects was evaluated on Fasting plasma triglyceride levels and postheparin lipolytic activity (PHLA). Uremia was associated with reduced postheparin lipolytic activity in all 10 patients, but serum triglycerides were elevated in only six, suggesting other factors drive hyperlipemia.
Synapse has enriched 10 related papers. Consider them for comparative context: